Skip to search.
 TSX Up 0.21% TSX Ventures Down 0.42%

More On AEZS

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Aeterna Zentaris Inc. (AEZS)

-NasdaqCM
3.43 Down 0.03(0.72%) 2:27PM EST - Nasdaq Real Time Price
Prev Close:3.45
Open:3.40
Bid:3.40 x 5900
Ask:3.45 x 300
1y Target Est:10.67
Beta:0.996441
Next Earnings Date:N/A
Day's Range:3.40 - 3.45
52wk Range:2.60 - 7.97
Volume:88,275
Avg Vol (3m):366,200
Market Cap:38.13M
P/E (ttm):N/A
EPS (ttm):-2.91
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
AEZSDown 0.72%38.13M
CELGUp 1.10%91.35B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):56.79
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-2.41
Quarterly EPS Est (Dec-16) :-0.77
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing novel treatments in oncology, endocrinology, and women's health. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback